Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Maisonneuve

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Recherche En Soins Infirmiers|June 1, 1996
[Analysis of professional applications of training given to general nursing care staff in continuing education]C Maisonneuve
Frontiers in Bioengineering and Biotechnology|July 11, 2022
Modeling Neurodegenerative Diseases Using <i>In Vitro</i> Compartmentalized Microfluidic DevicesLouise Miny, Benoît G C Maisonneuve, Isabelle Quadrio, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1995
[Necrolytic migrating erythema without glucagonoma]H Maillard, P Celerier, C Maisonneuve, et al.
Biomacromolecules|November 22, 2013
Effects of cell density and biomacromolecule addition on the flow behavior of concentrated mesenchymal cell suspensionsBenoît G C Maisonneuve, Denis C D Roux, Peter Thorn, et al.
Biomacromolecules|December 4, 2014
Effects of synthetic biomacromolecule addition on the flow behavior of concentrated mesenchymal cell suspensionsBenoît G C Maisonneuve, Denis C D Roux, Peter Thorn, et al.
Oncogene|April 19, 2006
Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histologyP Ruminy, F Jardin, J M Picquenot, et al.
Leukemia|January 19, 2007
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomasP Bertrand, C Bastard, C Maingonnat, et al.
Biomicrofluidics|March 26, 2016
Rapid mask prototyping for microfluidicsB G C Maisonneuve, T Honegger, J Cordeiro, et al.
Regulatory Toxicology and Pharmacology : RTP|March 30, 2010
Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar ratsJ-L Delongeas, G Vermeil de Conchard, A Beamonte, et al.
Microsystems & Nanoengineering|August 4, 2022
Deposition chamber technology as building blocks for a standardized brain-on-chip frameworkB G C Maisonneuve, L Libralesso, L Miny, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Recherche En Soins Infirmiers|June 1, 1996
[Analysis of professional applications of training given to general nursing care staff in continuing education]C Maisonneuve
Frontiers in Bioengineering and Biotechnology|July 11, 2022
Modeling Neurodegenerative Diseases Using <i>In Vitro</i> Compartmentalized Microfluidic DevicesLouise Miny, Benoît G C Maisonneuve, Isabelle Quadrio, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1995
[Necrolytic migrating erythema without glucagonoma]H Maillard, P Celerier, C Maisonneuve, et al.
Biomacromolecules|November 22, 2013
Effects of cell density and biomacromolecule addition on the flow behavior of concentrated mesenchymal cell suspensionsBenoît G C Maisonneuve, Denis C D Roux, Peter Thorn, et al.
Biomacromolecules|December 4, 2014
Effects of synthetic biomacromolecule addition on the flow behavior of concentrated mesenchymal cell suspensionsBenoît G C Maisonneuve, Denis C D Roux, Peter Thorn, et al.
Oncogene|April 19, 2006
Two patterns of chromosomal breakpoint locations on the immunoglobulin heavy-chain locus in B-cell lymphomas with t(3;14)(q27;q32): relevance to histologyP Ruminy, F Jardin, J M Picquenot, et al.
Leukemia|January 19, 2007
Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomasP Bertrand, C Bastard, C Maingonnat, et al.
Biomicrofluidics|March 26, 2016
Rapid mask prototyping for microfluidicsB G C Maisonneuve, T Honegger, J Cordeiro, et al.
Regulatory Toxicology and Pharmacology : RTP|March 30, 2010
Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar ratsJ-L Delongeas, G Vermeil de Conchard, A Beamonte, et al.
Microsystems & Nanoengineering|August 4, 2022
Deposition chamber technology as building blocks for a standardized brain-on-chip frameworkB G C Maisonneuve, L Libralesso, L Miny, et al.
Pageof 2